Dr. Jekkie Kim advises life sciences and technology companies, as well as their investors and lenders on a broad range of matters. She has extensive experience advising clients on complex corporate business transactions, including those related to artificial intelligence and digital health, and focuses her practice on emerging companies and venture capital matters, strategic licensing and collaborations, and complex commercial transactions.

Drawing on her background as a medical doctor with clinical experience and her role as a member of the Institutional Review Board at Mass General Brigham (formerly Massachusetts General Hospital), Dr. Kim provides sophisticated, effective, and practical strategies that are both creative and efficient for her clients throughout their lifecycle.

Dr. Kim regularly speaks and writes on AI, digital health, healthcare, and life sciences related topics. She is an advisor to Stanford SPARK, a translational program that allows Stanford students and professors to generate drug and diagnostic proofs-of-concept for potential commercialization, using academic approaches combined with industry standards.

Prior to joining the firm, Dr. Kim was a partner at another international law firm.

Recognition

  • Recognized as a "Next Generation Lawyer" in the area of Intellectual Property: Patent Licensing by The Legal 500 United States in 2026.

Insights & News

Credentials

  • Education

    • JD, Boston University, 2008

    • MBA, Case Western Reserve University, 2008

    • LLM, Yonsei University Department of Medical Law and Ethics, 2003

    • MD, Yonsei University College of Medicine, 2003

  • Admissions

    • California

    • Massachusetts

    • New York

  • Languages

    • Korean

Credentials

Notice

We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.